Skip to main content
Tech.euFundingExplorerBeta

Healthtech funding in Q3 2024

European Healthtech startup funding raised during Q3 2024.

In Q3 2024, 95 European Healthtech companies closed 95 funding rounds and raised €1.1B in equity funding (excluding debt and grants), down 69.7% versus Q3 2023. Debt rounds added €20M. UK led by capital raised, and High-Tech Gründerfonds (HTGF) was the most active investor. Data as of 20 Nov 2026.

Equity funding
€1.1B
-69.7% vs Q3 2023 · excl. debt & grants · +€20M debt
Funding rounds
95
-9.5% vs Q3 2023
Companies
95
Top country
UK
Rank among sectors
#4
10.4% of sector funding
Debt financing
€20M
1.7% of total
Top-10 round share
66.1%
of disclosed capital
Rounds ≥ €100M
2

Funding by month

€ raised vs rounds, by month
Healthtech — funding by month, Q3 2024 — interactive chart.
Data table
FundingRounds
Jul€425M31
Aug€364M25
Sep€367M39

Top countries

by € raised
Healthtech — top countries by capital, Q3 2024 — interactive chart.
Data table
Healthtech — top countries by capital, Q3 2024
UK€564M
Germany€258M
France€118M
Switzerland€112M
Spain€29M
Belgium€23M
Denmark€17M
Austria€13M

Stage mix

by € raised
Healthtech — stage mix, Q3 2024 — interactive chart.
Data table
Healthtech — stage mix, Q3 2024
Series C€358M
Other€357M
Series A€129M
Series D+€119M
Series B€108M
Seed€46M
Debt€20M
Grant€13M
Pre-Seed€4.9M

Exits & M&A

6 Acquisition · 1 Merger

8 exits.

Top deals

largest disclosed rounds in Q3 2024
CompanyStageDateAmount
Flo HealthSeries CJul 2024€185M
CaresyntaxSeries CAug 2024€164M
HumaSeries D+Jul 2024€73M
Neo MedicalOtherSep 2024€61M
Oxford Nanopore TechnologiesOtherAug 2024€59M
Constructive BioSeries ASep 2024€52M
TRIcaresSeries D+Jul 2024€46M
HealxOtherAug 2024€44M
DocclaSeries BSep 2024€42M
PhoreMostSeries BSep 2024€39M
Abolis BiotechnologiesOtherSep 2024€35M
VandriaSeries AAug 2024€28M
ProtembisDebtJul 2024€20M
BrightflowSeries ASep 2024€17M
VaxdynOtherSep 2024€15M

Top investors

most active in Q3 2024, by deal count